These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 337477)

  • 1. [Treatment possibilities of arterial circulatory disorders using calcitonin].
    Staehelin A
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1865-7. PubMed ID: 337477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Angiological problems of calcitonin therapy (author's transl)].
    Staehelin A
    Schweiz Rundsch Med Prax; 1979 May; 68(19):606-12. PubMed ID: 377271
    [No Abstract]   [Full Text] [Related]  

  • 3. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta blockers and peripheral blood circulation. Can the restrictions for indication still be maintained?].
    Diehm C
    MMW Munch Med Wochenschr; 1983 Jan; 125(2):27-8. PubMed ID: 6132334
    [No Abstract]   [Full Text] [Related]  

  • 5. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.
    Leschke M; Schoebel FC; Strauer BE
    Clin Hemorheol Microcirc; 1997; 17(1):59-66. PubMed ID: 9181759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 8. [Training by walking and drug therapy of peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
    Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
    [No Abstract]   [Full Text] [Related]  

  • 9. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution].
    Visconti W; Grillo N
    Minerva Med; 1985 May; 76(19-20):945-53. PubMed ID: 3158842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasodilation caused by inhibition of calcium ions as a factor of increasing oxygen transport in peripheral vascular diseases].
    Pola P; Savi L; Dal Lago A; Zucchiatti V
    Clin Ter; 1977 Jun; 81(5):417-31. PubMed ID: 884936
    [No Abstract]   [Full Text] [Related]  

  • 11. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A; Tascino C; Costa F
    Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 13. [On a case of "ergotaminomania"].
    Nattero G; Gastaldi L; Gai V
    Riv Crit Clin Med; 1968; 68():Suppl 6:1129+. PubMed ID: 5747754
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
    Zöllner N; Keller C; Wolfram G
    Med Klin; 1976 Apr; 71(18):768-74. PubMed ID: 818496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effective therapy of chronic arterial circulatory disorders with Nico-Padutin forte (author's transl)].
    Vorberg G
    MMW Munch Med Wochenschr; 1976 Oct; 118(44):1429-32. PubMed ID: 825753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK
    Med Welt; 1973 Sep; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract]   [Full Text] [Related]  

  • 17. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostanoids in therapy of peripheral arterial occlusive disease.
    Creutzig A; Caspary L
    Therapie; 1991; 46(3):241-5. PubMed ID: 1792658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
    Spinella G; Majorana M
    Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of calcitonin on limb blood vessels in human obstructive arterial disease.
    Franchi F; Chiarini P; Matassi L; Strazzulla G; Scardi A; Righi D; Nuzzaci G
    Int J Clin Pharmacol Res; 1983; 3(2):115-28. PubMed ID: 6679513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.